1 – 47 of 47
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Thyroid disease in ANCA-associated vasculitis : a clinical and epidemiological study
(
- Contribution to journal › Article
-
Mark
Epidemiology and clinical characteristics of biopsy-confirmed adult-onset IgA vasculitis in southern Sweden
(
- Contribution to journal › Article
-
Mark
Apolipoproteins and the risk of giant cell arteritis—a nested case–control study
(
- Contribution to journal › Article
-
Mark
Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden
(
- Contribution to journal › Article
-
Mark
Mortality Rate by Diagnosis in ANCA-Associated Vasculitis Across FAIRVASC Registries
2024) p.187-187(
- Contribution to conference › Abstract
-
Mark
The HLA region in ANCA-associated vasculitis : characterisation of genetic associations in a Scandinavian patient population
(
- Contribution to journal › Article
-
Mark
EULAR recommendations for the management of ANCA-associated vasculitis : 2022 update
(
- Contribution to journal › Article
- 2023
-
Mark
High risk of stroke in ANCA-Associated vasculitis-a population-based study
(
- Contribution to journal › Article
-
Mark
Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides
(
- Contribution to journal › Article
-
Mark
Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis : a prospective study
(
- Contribution to journal › Article
-
Mark
Stratified Genetic Analysis Reveals Sex Differences In MPO-ANCA-associated Vasculitis
(
- Contribution to journal › Article
-
Mark
Data quality and patient characteristics in European ANCA-associated vasculitis registries : data retrieval by federated querying
(
- Contribution to journal › Article
-
Mark
Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis : A Multinational Retrospective Study
(
- Contribution to journal › Article
- 2022
-
Mark
Pathogenesis of giant cell arteritis with focus on cellular populations
(
- Contribution to journal › Scientific review
-
Mark
Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes
(
- Contribution to journal › Article
-
Mark
An update on polymyalgia rheumatica
(
- Contribution to journal › Scientific review
-
Mark
Global epidemiology of vasculitis
(
- Contribution to journal › Scientific review
-
Mark
The Role of Sural Nerve Biopsy in the Diagnosis of Vasculitis
(
- Contribution to journal › Article
-
Mark
Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
(
- Contribution to journal › Article
-
Mark
Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA
(
- Contribution to journal › Article
-
Mark
The Sound of Interconnectivity; The European Vasculitis Society 2022 Report
(
- Contribution to journal › Article
- 2021
-
Mark
High risk of coronary artery aneurysm in Kawasaki disease
(
- Contribution to journal › Article
-
Mark
Venous thromboembolism in ANCA-associated vasculitis : A population-based cohort study
(
- Contribution to journal › Article
-
Mark
Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis – A Population-Based Study
(
- Contribution to journal › Article
-
Mark
Comment on : Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: Reply
(
- Contribution to journal › Letter
-
Mark
Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study
(
- Contribution to journal › Article
-
Mark
Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis : A multinational study
(
- Contribution to journal › Article
- 2020
-
Mark
An update on the epidemiology of ANCA-associated vasculitis
(
- Contribution to journal › Scientific review
-
Mark
Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis : a population-based case-control study
(
- Contribution to journal › Article
-
Mark
Malignancies In Giant Cell Arteritis : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis
(
- Contribution to journal › Article
-
Mark
International consensus on antineutrophil cytoplasm antibodies testing in eosinophilic granulomatosis with polyangiitis
(
- Contribution to journal › Article
- 2019
-
Mark
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
(
- Contribution to journal › Article
-
Mark
Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
2019) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 34(2). p.301-308(
- Contribution to journal › Article
- 2018
-
Mark
Hospitalizations due to systemic connective tissue diseases: : Secular trends and regional disparities in Sweden, 1998-2016
(
- Contribution to journal › Article
-
Mark
Comment on : Rituximab therapy for takayasu arteritis: A seven patients experience and a review of the literature
(
- Contribution to journal › Letter
-
Mark
Long-term outcomes of patients with Takayasu arteritis and renal artery involvement : A cohort study
(
- Contribution to journal › Article
-
Mark
Brief Report : Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein)
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term patient survival in a Swedish population-based cohort of patients with ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Rate of comorbidities in giant cell arteritis : A population-based study
(
- Contribution to journal › Article
-
Mark
Development of a score for assessment of radiologic damage in large-vessel vasculitis (Combined Arteritis Damage Score, CARDS)
(
- Contribution to journal › Article
-
Mark
Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis : The influence of ANCA subtype
(
- Contribution to journal › Article
- 2016
-
Mark
Comorbidities in patients with antineutrophil cytoplasmic antibody-associated vasculitis versus the general population
(
- Contribution to journal › Article
-
Mark
Visual complications in patients with biopsy-proven giant cell arteritis : A population-based study
(
- Contribution to journal › Article
-
Mark
The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis
(
- Contribution to journal › Article
- 2015
-
Mark
Incidence and disease severity of anti-neutrophil cytoplasmic antibody-associated nephritis are higher than in lupus nephritis in Sweden.
(
- Contribution to journal › Article